Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice

Immunity

Volumn 4, Issue 4, 1996, Pages 407-414

  Haziot, Alain ^a   Ferrero, Enza ^a,d   Köntgen, Frank ^b   Hijiya, Naoki ^a   Yamamoto, Shunsuke ^c   Silver, Jack ^a   Stewart, Colin L ^b   Goyert, Sanna M ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

^c OITA UNIVERSITY   (Japan)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CYTOKINE; ENDOTOXIN;

ANIMAL EXPERIMENT; ARTICLE; CONGENITAL DISORDER; CONTROLLED STUDY; GENE TARGETING; GRAM NEGATIVE BACTERIUM; HOST RESISTANCE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHOCK;

EID: 0029919991     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80254-X     Document Type: Article

References (38)

1. Akira, S., Taga, T., and Kishimoto, T. (1993). Interleukin-6 in biology and medicine. Adv. Immunol. 54, 1-78.
2. Bone, R.C. (1991). The pathogenesis of sepsis. Ann. Intern. Med. 115, 457-469.
3. Bright, S.W., Chen, T.Y., Flebbe, L.M., Lei, M.G., and Morrison, D.C. (1990). Generation and characterization of hamster-mouse hybridomas secreting monoclonal antibodies with specificity for lipopolysaccharide receptor. J. Immunol. 145, 1-7.
4. Decker, K., and Keppler D. (1974). Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev. Physiol. Biochem. Pharmacol. 71, 77-82.
5. Ferrero, E., Jiao, D., Tsuberi, B., Tesio, L., Rong, G.W., Haziot, A., and Goyert, S.M. (1993). Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 90, 2380-2384.
6. Frey, E.A., Miller, D.S., Jahr, T.G., Sundan, A., Bazil, V., Espevik, T., Finlay, B.B., and Wright, S.D. (1992). Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176, 1665-1671.
7. Galanos, C., and Freudenberg, M.A. (1993). Mechanisms of endotoxin shock and endotoxin hypersensitivity. Immunobiology 187, 346-356.
8. Galanos, C., Freudenberg, M.A., and Reutter, W. (1979). Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. USA. 7, 5939-5947.
9. Goyert, S.M., Ferrero, E., Rettig, W.J., Yenamandra, A.K., Obata, F., and Le Beau, M.M. (1988). The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 239, 497-500.
10. Grunwald, U., Krüger, C., Westermann, J., Lukowsky, A., Ehlers, M., and Schütt., C. (1992). An enzyme-linked immunosorbent assay for the quantitation of solubilized CD14 in biological fluids. J. Immunol. Meth. 155, 225-232.
11. Hampton, R.Y., Golenbock, D.T., Penman, M., Krieger, M., and Raetz, C.R. (1991). Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 352, 342-344.
12. Haziot, A., Chen, S., Ferrero, E., Low, M.G., Silber, R., and Goyert, S.M. (1988). The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J. Immunol. 141, 547-552.
13. Haziot, A., Tsuberi, B., and Goyert, S.M. (1993a). Neutrophil CD14: biochemical properties and role in the secretion of TNFα in response to LPS. J. Immunol. 150, 5556-5565.
14. Haziot, A., Rong, G.W., Silver, J., and Goyert, S.M. (1993b). Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J. Immunol. 151, 1500-1507.
15. Haziot, A., Rong, G.W., Bazil, V., Silver, J., and Goyert, S.M. (1994). Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-α production by cells in whole blood. J. Immunol. 152, 5868-5876.
16. Haziot, A., Rong, G.W., Lin, X.Y., Silver, J., and Goyert, S.M. (1995). Recombinant soluble CD14 prevents mortality in mice treated with endotoxin (lipopolysaccharide). J. Immunol. 154, 6529-6532.
17. d) macrophages requires the presence of lipid-A-associated proteins. J. Immunol. 141, 4196-4202.
18. Ingalls, R.R., and Golenbock, D.T. (1995). CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide. J. Exp. Med. 181, 1473-1479.
19. Kitchens, R.L., Ulevitch, R.J., and Munford R. S. (1992). Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J. Exp. Med. 176, 485-494.
20. Koch, T., Duncker, H., Axt, R., Schiefer, H., van Ackern, K., and Neuhof, H. (1993). Alterations of bacterial clearance induced by endotoxin and tumor necrosis factor. Infect. Immun. 61, 3143-3148.
21. Köntgen, F., and Stewart, C.L. (1993). Simple screening procedure to detect gene targeting events in embryonic stem cells. Meth. Enzymol. 225, 878-890.
22. Lehmann, V., Freudenberg, M.A., and Galanos. C. (1987). Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J. Exp. Med. 165, 657-663.
23. Lei, M.G., and Morrison, D.C. (1988). Specific endotoxic lipopolysaccharide-binding proteins on murine splenocytes. I. Detection of lipopolysaccharide-binding sites on splenocytes and splenocyte subpopulations. J. Immunol. 141, 996-1005.
24. Lei, M.G., Stimpson, S.A., and Morrison, D.C. (1991). Specific endotoxic lipopolysaccharide-binding receptors on murine splenocytes. III. Binding specificity and characterization. J. Immunol. 147, 1925-1932.
25. Li, E., Bestor, T.H., and Jaenisch, R. (1992). Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915-926.
26. Luo, G., Niesel, D., Shaban, R., Grimm, E., and Klimpel, G. (1993). Tumor necrosis factor alpha binding to bacteria: evidence for a high-affinity receptor and alteration of bacterial virulence properties. Infect. Immun. 61, 830-835.
27. Matsuura, K., Ishida, T., Setoguchi, M., Higuchi, Y., Akizuki, S., and Yamamoto, S. (1994). Upregulation of mouse CD14 expression in Kupffer cells by lipopolysaccharide. J. Exp. Med. 179, 1671-1676.
28. Morrison, D.C., and Ryan, J.L. (1987). Endotoxins and disease mechanisms. Annu. Rev. Med. 38, 417-432.
29. Porat, R., Clark, B., Wolff, S., and Dinarello, C. (1991). Enhancement of growth of virulent strains of Escherichia coli by interleukin-1. Science 254, 430-432.
30. Pugin, J., Schurer-Maly, C.C., Leturcq, D., Moriarty, A., Ulevitch, R.J., and Tobias, P.S. (1993). Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 90, 2744-2748.
31. Rietschel, E.T., Kirikae, T., Schade, F.U., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A.J., Zahringer, U., Seydel, U., Di Padova, F., Schreier, M., and Brade, H. (1994). Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8, 217-225.
32. Stewart, C.L. (1993). Production of chimeras between embryonic stem cells and embryos. Meth. Enzymol. 225, 823-855.
33. Sun, X., and Hsueh, W. (1991). Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice. J. Immunol. 147, 509-514.
34. Thomas, K.R., and Capecchi, M.R. (1987). Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51, 503-512.
35. Tracey, K., and Cerami, A. (1994). Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45, 491-503.
36. Wallis, R.S. (1991). PROBIT: a computer program analysis. J. Immunol. Meth. 65, 55-56.
37. Wendel, A. (1990). Biochemical pharmacology of inflammatory liver injury in mice. Meth. Enzymol. 186, 675-680.
38. Wright, S.D., Ramos, R.A., Tobias, P.S., Ulevitch, R.J., and Mathison, J.C. (1990). CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431-1433.